|
Market Cap (24-May) $66,720,148 (584th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 696,012 |
Shortsold (16-Jan) 98 (0.00%) (641st) |
|
52w High $0.099 |
52w Low $0.021 |
P/E 25.97 |
EPS 0 |
ACW released this announcement to the ASX on 22 October 2020, 12:38. The announcement is not marked as price sensitive, and is 16 page(s) in length and 167.93kb in size.
You can view all announcements from ACW and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACW was 0.040% short sold according to ASIC data. It was ranked the 452nd most shorted stock on the ASX. It remains ranked 641st as of the latest reported data (16 January 2025).
| Other Recent Announcements from ACW | |
|---|---|
| ACW CEO presentation on emerging oral Alzheimers therapies | 21 June 2023, 8:50 |
| ACW CEO & CMO present at BIO International Convention | 5 June 2023, 9:06 |
| ACW AD trial amendment and Clinical Science Forum slides | 24 May 2023, 8:20 |
| Appendix 2A | 22 October 2020, 12:38 |
| Change to Date of Annual General Meeting | 16 October 2020, 17:07 |
| Letter to Optionholders re Non-Renounceable Rights Issue | 15 October 2020, 17:53 |
| Notice under Section 708AA of the Corporations Act 2001 (Cth | 15 October 2020, 9:45 |
You must be logged in to post a reply.
Actinogen Medical 